摘要
目的:观察消癌平注射液联合TP方案治疗晚期非小细胞肺癌(NSCLC)的临床疗效。方法:78例晚期NSCLC患者随机分为对照组和治疗组。对照组:紫杉醇135mg/m2,第1天,静脉滴注,顺铂30mg/m2,第1天~第3天,静脉滴注(TP方案);治疗组:消癌平注射液联合TP方案,两组病例的临床资料具有可比性。均每21d为1个治疗周期。结果:治疗组在近期疗效、生活质量方面均优于对照组,差异有统计学意义(P<0.05);治疗组毒副反应略低。结论:消癌平注射液联合TP方案治疗晚期NSCLC的疗效较好,可有效改善临床症状,提高生存质量及降低不良反应。
Objective:To observe the curative effect of xiaoaiping injection combined with TP regimen in treat- ment of advanced non-small celllung cancer (NSCLC). Methods :Seventy-night patients with terminal NSCLC patients were divided into the control group and the treatment group. The control group :paclitaxel 135 mg/m2,the 1st day in- travenous drip, cisplatin 30 mg/m2, the 1st day ~ 3rd day, intravenous drip (TP regimen). The treatment group : xi- aoaiping injection combined with TP regimen. The clinical data of two groups was comparable. Every 21 days for a treatment cycle. Results:The short-term curative effect,life quality in treatment group is better than the control. group. There was statistical significance(P〈0.05). The adverse effect of treatment group was slightly lower. Conclu- sion :Xiaoaiping injection incombination with TP regimen in treatment of non-small cell lung cancer has better effica- cy ,effectively improves the clinical symptoms and improves quality of life and less adverse reaction.
出处
《临床医药实践》
2013年第2期83-85,共3页
Proceeding of Clinical Medicine
关键词
消癌平注射液
非小细胞肺癌
化疗
xiaoaiping injection
non-small cell lung cancer
chemotherapy